Neurogene (NGNE) Operating Leases (2019 - 2026)

Neurogene (NGNE) has 8 years of Operating Leases data on file, last reported at $6.1 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases fell 29.36% year-over-year to $6.1 million; the trailing twelve-month figure through Mar 2026 stood at $6.1 million (down 29.36% YoY), and the FY2025 full-year result was $6.8 million, down 44.75% from the prior year.
• Operating Leases for Q1 2026 stood at $6.1 million, down from $6.8 million in the prior quarter.
• Across five years, Operating Leases topped out at $14.9 million in Q4 2023 and bottomed at $4.6 million in Q4 2022.
• The 5-year median for Operating Leases is $9.9 million (2023), against an average of $9.6 million.
• The widest annual swing landed in 2022, when Operating Leases soared 359.9%; it then sank 44.75% in 2025.
• A 5-year view of Operating Leases shows it stood at $4.6 million in 2022, then jumped by 223.14% to $14.9 million in 2023, then decreased by 16.91% to $12.3 million in 2024, then tumbled by 44.75% to $6.8 million in 2025, then slipped by 10.89% to $6.1 million in 2026.
• The last three Operating Leases figures came in at $6.1 million (Q1 2026), $6.8 million (Q4 2025), and $7.1 million (Q3 2025), per Business Quant data.

Peer Comparison